Several studies have detected a decrease in cyclin B1 levels and an increase in cell cycle progression inhibitors p21 and p27 upon alisertib-induced cell cycle arrest in breast, ovarian and pancreatic cancer cells [37,38,84]. The gene discussed is CCNB1; the disease is pancreatic neoplasm.